(alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt)

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

2 Suppliers, 2 USDMF

PRICE INFORMATION

API Reference Price

API Reference Price

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

16 Dossiers, 4 FDA Orange Book, 5 Europe, 3 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 200MG BASE, CAPSULE;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 7 Kerry, 6 Microlex e.U, 5 BASF, 4 ACG Worldwide, 3 Lonza Capsugel, 2 Roquette, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Gangwal Chemicals, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 DFE Pharma, 1 Prachin Chemical, 1 Gangwal Healthcare, 1 Qualicaps, 1 Sigachi Industries, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders, 11 Lubricants & Glidants, 8 Empty Capsules, 5 Coating Systems & Additives, 4 Direct Compression, 3 Granulation, 3 Co-Processed Excipients, 3 Taste Masking, 2 Emulsifying Agents, 2 Thickeners and Stabilizers, 2 Controlled & Modified Release, 2 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Topical

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 3 Finished Drug Prices

PATENTS

4 Health Canada Patents

4 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

Approved Drug Products containing (alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt) listed in the FDA Orange Book. Original Data : FDA Website

(alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt)

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

2 Suppliers

2 USDMF

PRICE INFORMATION

API Reference Price

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

16 Dossiers

4 FDA Orange Book

5 Europe

3 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 200MG BASE

CAPSULE;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

7 Kerry

6 Microlex e.U

5 BASF

4 ACG Worldwide

3 Lonza Capsugel

2 Roquette

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Gangwal Chemicals

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 DFE Pharma

1 Prachin Chemical

1 Gangwal Healthcare

1 Qualicaps

1 Sigachi Industries

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders

11 Lubricants & Glidants

8 Empty Capsules

5 Coating Systems & Additives

4 Direct Compression

3 Granulation

3 Co-Processed Excipients

3 Taste Masking

2 Emulsifying Agents

2 Thickeners and Stabilizers

2 Controlled & Modified Release

2 Film Formers & Plasticizers

1 API Stability Enhancers

1 Topical

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

3 Finished Drug Prices

PATENTS

4 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards

2 USP Standards

2 Other Ref. Standards

CAPSULE;ORAL

EQ 400MG BASE

1996-03-13

20685

CRIXIVAN

DISCN

Yes

CAPSULE;ORAL

EQ 200MG BASE

1996-03-13

20685

CRIXIVAN

DISCN

Yes

CAPSULE;ORAL

EQ 333MG BASE

1998-12-17

20685

CRIXIVAN